Compare RDY & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | VIAV |
|---|---|---|
| Founded | 1984 | 1923 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.0B |
| IPO Year | 2001 | 1996 |
| Metric | RDY | VIAV |
|---|---|---|
| Price | $12.18 | $35.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $16.90 | ★ $32.66 |
| AVG Volume (30 Days) | 2.3M | ★ 4.4M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,518,300,000.00 |
| Revenue This Year | $7.72 | $37.78 |
| Revenue Next Year | $3.50 | $10.64 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | ★ 40.03 |
| 52 Week Low | $11.36 | $11.43 |
| 52 Week High | $15.67 | $60.43 |
| Indicator | RDY | VIAV |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 39.85 |
| Support Level | $11.99 | $34.83 |
| Resistance Level | $12.38 | $35.61 |
| Average True Range (ATR) | 0.16 | 2.09 |
| MACD | 0.03 | -0.38 |
| Stochastic Oscillator | 32.69 | 6.26 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.